Trial Profile
A study to evaluate the levodopa-related cysteinyl-glycine and cysteine reduction with and without catechol-O-methyltransferase inhibition in patiets with Parkinson´s disease patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Levodopa/carbidopa/entacapone (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 15 Dec 2015 New trial record